Fiche centre
CHU de Strasbourg
Strasbourg — France
Essais liés2clinical trials
VilleStrasbourglocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05999604
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Ocrelizumab Injection [Ocrevus] | SEP | Phase 3 | NCT05999604 | WINDOCRE — Impact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS,After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority Trial | ACTIVE_NOT_RECRUITING |
| Teriflunomide | SEP | Phase 3 | NCT02587195 | TERICIS — A Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension Period | COMPLETED |